| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $10.80 | - | - |
| Q1'26 | $8.79 | $8.91 | +1.4% |
| Q4'25 | $12.93 | $13.36 | +3.3% |
| Q3'25 | $10.66 | $11.15 | +4.6% |
| Q2'25 | $9.60 | $10.09 | +5.1% |
| Q1'25 | $7.88 | $8.19 | +3.9% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $1.0B | - | - |
| Q1'26 | $951M | $947M | -0.4% |
| Q4'25 | $1.1B | $1.1B | +1.3% |
| Q3'25 | - | $1.0B | - |
| Q2'25 | - | $983M | - |
| Q1'25 | - | $884M | - |
Market Data
MTD is currently trading at $1296.17, giving Mettler-Toledo International Inc. a market cap of 26.03B and a P/E ratio of 29.8. Today's range spans $1279.36–$1303.45, with shares opening at $1295.92 and moving down $0.04 (0.0%) from the prior close. DailyIQ's technical score sits at 64/100 (HOLD) with a news sentiment reading of 50/100.
Over the past year MTD has traded between $1023.05 and $1525.17 - the current price is +26.7% off the 52-week low and -15.0% from the high. 22 analysts cover the stock with a Hold consensus and a mean 12-month target of $1315.33 (range $1194.00–$1550.00), implying upside of +1.5%.
It's a pause for MTD: technical score 64/100 (HOLD), sentiment neutral (50/100), price $1296.17 (in the middle of its 52-week range). (P/E: 29.8) At 26.03B in Healthcare market cap, pauses like this often occur when the stock has run ahead of near-term fundamental catalysts and is waiting for earnings or macro data to validate the prior move. Annual range: $1023.05–$1525.17. The consolidation is the story for now.
In neutral phases, large-cap Healthcare names like MTD are often where sector rotation debates play out quietly — at 26.03B in capitalization, the stock receives incremental allocation from funds reducing mega-cap exposure without the volatility of a small-cap entry. The 64/100 (HOLD) and neutral sentiment (50/100) at $1296.17 (in the middle of its 52-week range) describe a stock that is being considered rather than avoided.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).